Anixa Biosciences, Inc.: Q3 2026 results
Published 9. 9. 2026, after the market closes. EPS -0,08 $ against an estimate of -0,08.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.